Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.7441
-0.0382 (-4.88%)
At close: Oct 1, 2026, 4:00 PM EDT
0.729551
-0.0145 (-1.96%)
After-hours: Oct 1, 2026, 7:37 PM EDT
Onconetix Revenue
Onconetix had revenue of $17.12K in the quarter ending June 30, 2026, a decrease of -83.92%. This brings the company's revenue in the last twelve months to $645.82K, down -51.33% year-over-year. In the year 2025, Onconetix had annual revenue of $815.37K, down -67.70%.
Revenue (ttm)
$645.82K
Revenue Growth
-51.33%
P/S Ratio
4.55
Revenue / Employee
$322,912
Employees
2
Market Cap
2.94M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 815.37K | -1.71M | -67.70% |
| Dec 31, 2024 | 2.52M | 2.47M | 4,217.31% |
| Dec 31, 2023 | 58.47K | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| HCW Biologics | 6.72M |
| PMGC Holdings | 2.58M |
| SciSparc | 1.14M |
| GeoVax Labs | 852.28K |
| BioRestorative Therapies | 357.87K |
| VivoSim Labs | 112.00K |
| Addex Therapeutics | 102.81K |
| Jupiter Neurosciences | 64.69K |
ONCO News
- 7 days ago - SRX Global says adds investment in Onconetix - TheFly
- 14 days ago - Onconetix Proxy statement: Proxy filing - Filings
- 17 days ago - CORRECTED: Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition - GlobeNewsWire
- 17 days ago - Onconetix Provides Strategic Bridge Financing to Realbotix LLC in Support of Pending Acquisition - GlobeNewsWire
- 17 days ago - Onconetix Proxy statement: Proxy filing - Filings
- 17 days ago - Realbotix announces bridge loan from Onconetix - TheFly
- 4 weeks ago - Onconetix Acquisition Target Realbotix Launches Pilot with Leading European Telecommunications Company to Deploy Humanoid Robots in Live Presentations and Events - GlobeNewsWire
- 4 weeks ago - Onconetix Registration statement: Registration filing - Filings